IRIS
LUCARELLI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.222
NA - Nord America 1.853
EU - Europa 1.421
SA - Sud America 263
AF - Africa 67
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.830
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.768
SG - Singapore 951
RU - Federazione Russa 718
VN - Vietnam 459
CN - Cina 433
BR - Brasile 202
IT - Italia 181
HK - Hong Kong 136
DE - Germania 126
FR - Francia 95
GB - Regno Unito 93
NL - Olanda 71
IN - India 58
FI - Finlandia 44
CA - Canada 38
AR - Argentina 32
KR - Corea 32
JP - Giappone 30
MX - Messico 28
BD - Bangladesh 20
ZA - Sudafrica 19
CI - Costa d'Avorio 18
PH - Filippine 14
PL - Polonia 13
TH - Thailandia 13
UA - Ucraina 11
AT - Austria 10
IQ - Iraq 10
TR - Turchia 10
ES - Italia 9
ID - Indonesia 9
PK - Pakistan 9
LT - Lituania 7
CZ - Repubblica Ceca 6
EC - Ecuador 6
EG - Egitto 6
SE - Svezia 6
UZ - Uzbekistan 6
DK - Danimarca 5
IR - Iran 5
JM - Giamaica 5
MA - Marocco 5
PY - Paraguay 5
CL - Cile 4
CO - Colombia 4
IE - Irlanda 4
JO - Giordania 4
LV - Lettonia 4
NP - Nepal 4
VE - Venezuela 4
AU - Australia 3
CH - Svizzera 3
GR - Grecia 3
IL - Israele 3
KE - Kenya 3
KG - Kirghizistan 3
PA - Panama 3
PE - Perù 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
NG - Nigeria 2
NI - Nicaragua 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CD - Congo 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GM - Gambi 1
HR - Croazia 1
IM - Isola di Man 1
KZ - Kazakistan 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
ML - Mali 1
MW - Malawi 1
MY - Malesia 1
NE - Niger 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 5.830
Salva come PNG Salva come JPEG
Città #
Singapore 476
San Jose 335
Ashburn 208
Moscow 162
Hefei 137
Hong Kong 132
Chandler 126
Ho Chi Minh City 120
Beijing 115
Hanoi 91
Santa Clara 72
Naples 65
Amsterdam 63
Munich 58
Dong Ket 56
Los Angeles 54
The Dalles 52
Lauterbourg 47
Enfield 41
New York 34
Millbury 31
Frankfurt am Main 27
Turku 26
Kochi 25
Redondo Beach 25
Seoul 25
Tokyo 25
Dallas 24
Lawrence 24
Des Moines 22
Boston 21
Buffalo 21
Council Bluffs 20
São Paulo 20
Haiphong 19
London 18
Phoenix 18
Da Nang 16
Orem 15
Chicago 12
Mexico City 12
Milan 12
Helsinki 11
Johannesburg 11
Montreal 11
Ottawa 11
Seattle 11
Warsaw 11
Bari 9
Chennai 9
Napoli 9
Nuremberg 9
Biên Hòa 8
Brooklyn 8
Houston 8
Wilmington 8
Denver 7
Lappeenranta 7
Paris 7
Baghdad 6
Düsseldorf 6
Fairfield 6
Ha Long 6
Nanjing 6
Ninh Bình 6
Pune 6
Toronto 6
Vienna 6
Ankara 5
Atlanta 5
Belo Horizonte 5
Cairo 5
Can Tho 5
Guangzhou 5
Kronberg 5
Poplar 5
Princeton 5
Shanghai 5
Amman 4
Bangkok 4
Bexley 4
Boardman 4
Bắc Giang 4
Concepción 4
Dearborn 4
Dhaka 4
Dublin 4
Manchester 4
Riga 4
Rome 4
San Francisco 4
Siziano 4
Stockholm 4
Tashkent 4
Woodbridge 4
Augusta 3
Bengaluru 3
Brasília 3
Cambridge 3
Campinas 3
Totale 3.244
Salva come PNG Salva come JPEG
Nome #
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets 208
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 172
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 169
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 161
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 155
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis 155
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 153
The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk? 148
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 146
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives 145
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 144
Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers 143
Epigenetic signature: A new player as predictor of clinically significant prostate cancer (PCa) in patients on active surveillance (AS) 142
Beyond PSA: The Role of Prostate Health Index (phi) 142
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 142
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 142
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 141
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings 139
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer 136
The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial 134
Integration of lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma 133
Prostate cancer radiogenomics—from imaging to molecular characterization 133
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy 129
Liquid biopsy biomarkers in urine: A route towards molecular diagnosis and personalized medicine of bladder cancer 128
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 126
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 126
The evolving landscape of renal surgery for complex renal masses (CRM): implications for oncologic and functional outcomes 125
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review 124
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 124
Novel Key Ingredients in Urinary Tract Health-The Role of D-mannose, Chondroitin Sulphate, Hyaluronic Acid, and N-acetylcysteine in Urinary Tract Infections (Uroial PLUS®) 122
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer 121
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 121
SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study 121
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 120
Radiomics in prostate cancer: an up-to-date review 119
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies 119
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 118
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice 109
Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity 103
Quality of Web-Based Patient Information on Robotic Radical Cystectomy Remains Poor: A Standardized Assessment 102
Percutaneous Ablation vs Robot-Assisted Partial Nephrectomy for Completely Endophytic Renal Masses: A Multicenter Trifecta Analysis with a Minimum 3-Year Follow-Up 76
Molecular Imaging Diagnosis of Renal Cancer Using 99mTc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques 76
Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects 71
Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer 67
Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice 63
Radiotherapy to the Primary Tumor: The First Step of a Tailored Therapy in Metastatic Prostate Cancer 60
Microwave versus cryoablation and radiofrequency ablation for small renal mass: a multicenter comparative analysis 53
Totale 5.906
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.978
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.978
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022189 7 3 4 0 2 2 1 3 6 22 70 69
2022/2023436 29 11 16 7 50 38 1 41 60 128 53 2
2023/2024290 6 55 60 22 16 15 5 38 5 2 51 15
2024/20251.649 64 80 0 11 53 61 160 88 133 221 654 124
2025/20263.141 339 288 354 311 495 143 391 154 355 182 75 54
2026/202712 12 0 0 0 0 0 0 0 0 0 0 0
Totale 5.906